$PFE Phase 2 Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis…NCT03903822. Estimated Primary Completion Date -  05/2020